Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Healius.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Experts deliver their verdict on the Healius imaging deal and it’s ‘yeah nah’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks end the week ahead despite freaky inflation data
Experts
Blood is thicker this quarter: Part 2. Healius
Experts
Blood is thicker this quarter: Morningstar’s pathological outliers. Part 1. Sonic Healthcare
Health & Biotech
ASX Health Stocks: Healius rips higher as new CEO takes over; Nova Eye bags record US sales
Health & Biotech
ScoPo’s Powerplays: Health stocks fall as tight hospital budgets hurt Nanosonics
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘up and down’ reporting season
News
2024: All the latest broker moves
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ASX Health Stocks: ACCC shoots down merger between pathology stocks ACL and Healius
News
ASX Small Caps Lunch Wrap: Lack of leadership has Aussie stocks flailing ahead of Big Wednesday CPI read
News
Traders’ Diary: Everything you need to get ready for the week ahead
News
Small Cap Lunch Wrap: The ASX… it’s as green and empty as a jungle in there
News
ASX Large Caps: Tech stocks sell off despite Nvidia’s 14x jump in profit; EBOS down 5pc after market update
News
Top 10 at 11: Boardroom battles and spinning drills are driving the market this morning
News
